Loading…

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

Like this presentation? Why not share!

Transparency and Pharmaceutical Practice from a MeTA Country

on

  • 2,050 views

Presentation by Normita D. Leyesa, President, Philippine Pharmacists Association on Transparency and Pharmaceutical Practice from a MeTA Country during the 69th FIP Congress, Istanbul, September 2009.

Presentation by Normita D. Leyesa, President, Philippine Pharmacists Association on Transparency and Pharmaceutical Practice from a MeTA Country during the 69th FIP Congress, Istanbul, September 2009.

Statistics

Views

Total Views
2,050
Views on SlideShare
2,049
Embed Views
1

Actions

Likes
0
Downloads
6
Comments
0

1 Embed 1

http://www.slideshare.net 1

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA
  • Title of presentation 17/09/09 MeTA

Transparency and Pharmaceutical Practice from a MeTA Country Transparency and Pharmaceutical Practice from a MeTA Country Presentation Transcript

  • Normita D. Leyesa, RPh, MS President, Philippine Pharmacists Association MeTA Council Member Transparency and Pharmaceutical Practice from a MeTA Country: The MeTA Philippines Country Report FIP-WHO META Istanbul, Turkey September 5, 2009
    • Medicine Transparency Alliance (MeTA) initiative proposes to improve access to medicines through transparency and accountability .
    FIP-WHO META Istanbul, Turkey September 5, 2009
  • FIP-WHO META Istanbul, Turkey September 5, 2009 The Philippines Work Plan for the Phase I 2009-2010 Objective: Provide adequate information that would strengthen decision-making and implementation of processes along the medicines registration , selection , procurement , and use .
  • Preparation of the Work Plan
    • Identification of priority areas for MeTA intervention by scoping visits, consultations, and stakeholder mapping
    • Identification of areas supported by other international development partners and stakeholders
    • Line-up of activities and allocated budget were finally deliberated and approved
    FIP-WHO META Istanbul, Turkey September 5, 2009
  • Three Key Points of Phase I
    • Country structure and commitment
    • Transparency: disclosure, data collection and analysis
    • Accountability: multi-stakeholder approach and good governance
    FIP-WHO META Istanbul, Turkey September 5, 2009
  • 2009-2010 Strategic Work Plan
    • Developing Information on Prices, Availability, Financing Mechanisms and Rational Drug Use
    • Generating Information to Improve Quality of Pharmaceuticals
    • Setting up Systems for Transparency in Medicines Registration, Selection, Procurement and Usage
    • Supporting Transparency Agenda in Decentralized Systems
    • Preparation of Budget for the Activities
    FIP-WHO META Istanbul, Turkey September 5, 2009
  • KEY OUTCOMES FIP-WHO META Istanbul, Turkey September 5, 2009
  • Key Outcome 1: Available information on medicines quality, registration, access, promotions, and rational drug use
    • Analysis of existing pharmaceutical data (ongoing)
    • Conduct of Level II and III Survey on medicines (ongoing)
    • Assessment of Public Sector
      • Procurement (including PITC) of medicines
      • Design of e -procurement system
      • Assessment of the current systems for financing medicines for the poor (TOR)
    • Survey of quality of medicines using the “FDA in a suitcase”
    • Study on medicines promotion and advertisement (TOR)
    FIP-WHO META Istanbul, Turkey September 5, 2009
  • Key Outcome 2: Setting up of information structures and systems
    • Improvement of the medicines registration
    • FDA website
    • Philippine National Drug Formulary Website
    • Support to the implementation of the Electronic Essential Drug Price Monitoring System (E-EDPMS) at the regional and provincial levels
    • Development of systems for monitoring and evaluation of ethical practices of industry and the medical profession
    • Development and testing of monitoring tools for prescription audits
    FIP-WHO META Istanbul, Turkey September 5, 2009
  • Key Outcome 3: Improvement of technical capacity for disclosure, analysis, and the use of information and evidence
    • Pharmaceutical Management and Good Governance Course for LGU Health Managers and Local Chief Executives
    • National Good Governance in Medicines Awards
    • Strengthening of Drug Therapeutic Committees (DTC) at Regional and Provincial levels
    • Technical capacity building for DTCs
    • Development of tools for monitoring/evaluation of DTCs
    • Piloting of the Pharmaceutical Bench Book
    FIP-WHO META Istanbul, Turkey September 5, 2009
  • Key Outcome 4: Setting up mechanism for advocacy and participation in decision making processes
    • MeTA Roundtable discussions
    • Publications
      • Development of the MeTA Website
      • Publication of Proceedings for MeTA Forum
      • Publication of Baseline Assessments
    • Annual MeTA Forum
    FIP-WHO META Istanbul, Turkey September 5, 2009
  • Key Outcome 5: Sustaining a Multi-stakeholder Collaboration
    • MeTA Council and Secretariat Operations
    • Support to Civil Society Organizations
      • Coalition for Health Advocacy and Transparency
    FIP-WHO META Istanbul, Turkey September 5, 2009
  • “ The challenges in transparency and accountability on medicine registration, selection, procurement, and use in the Philippines are enormous. These can be summed up into two: non-accessibility of data to policy, decision makers, and consumers and the lack of tools and structures for adequate reporting, disclosure and feedback.” FIP-WHO META Istanbul, Turkey September 5, 2009
    • With the assistance of MeTA International, and the Department of International Development (DFID) UK, and the support of the World Health Organization, we will be able to surmount these challenges and ultimately, improve the healthcare delivery system in the Philippines for the benefit of the Filipino people.
    FIP-WHO META Istanbul, Turkey September 5, 2009
  • Thank You! FIP-WHO META Istanbul, Turkey September 5, 2009